42 /100
MEDIUM RISK
Score updated May 30, 2026

COYA — Coya Therapeutics, Inc. Dilution Risk Tracker

Track COYA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COYA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
24%
📉 Score Deterioration 40%
• Score rose 21 points recently (worsening)
🔁 Convertible Conversion 15%
• Convertible debt present: 11.5% potential dilution
🔔 Track COYA — Get forecast alerts →

💹 Market Data

Market Cap$113.06M
Shares Outstanding23.46M
Float17.83M
Cash$50.72M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 65.2% shares (2025Q4 vs prior)
58 institutional holders · 7.94M shares
#1 DME Capital Management, LP 2.03M shares
#2 AIGH Capital Management LLC 975.4K shares
#3 VANGUARD GROUP INC 899.1K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest818.1K
Days to Cover4.0
% of Float4.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track COYA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking COYA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for COYA
📊 COYA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 COYA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.